Healthcare / BiotechnologyNasdaqCM
$3.53
-0.08 (-2.15%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 31% · confianza 25%
FCF escenarios
weak_data · normalized FCF $11.9M · quality 52.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
53/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$281M
P/E
16.8x
↓EV/EBITDA
15.2x
↑ROE
22.7%
↑Gross Margin
64.3%
↑Debt/Equity
0.04
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2011–2025 · 14 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
10.2%
FCF / Net income
0.76x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $129.4M · net income $17.4M · FCF $13.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | $129.4M | $129.4M | $99.6M | $83.6M | $72.0M | $67.4M | $59.3M | $46.3M | $31.6M | $21.2M | — | — | — | — | — |
| Net Income | $17.4M | $17.4M | $8.6M | $-4.9M | $-16.5M | $-27.1M | $-19.9M | $-32.1M | $-33.3M | $-11.4M | $-2.9M | $-5.4M | $-4.4M | $-11.7M | $-7.9M |
| EBITDA | $15.7M | $15.7M | $9.2M | $-3.9M | $-16.7M | — | — | — | $-32.6M | $-15.9M | $-2.6M | $-5.0M | $-4.1M | — | — |
| EPS | 0.20 | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 | -0.33 | — | — | — | — | — | — | — | -0.36 |
| Gross Margin | 64.3% | 64.3% | 61.8% | 60.8% | 59.4% | 61.5% | 59.5% | 55.7% | 50.9% | 49.4% | — | — | — | — | — |
| Operating Margin | 11.0% | 11.0% | 7.8% | -6.7% | -25.9% | -40.1% | -33.5% | -67.6% | -105.1% | -77.2% | — | — | — | — | — |
| Net Margin | 13.4% | 13.4% | 8.6% | -5.9% | -23.0% | -40.2% | -33.6% | -69.4% | -105.6% | -53.7% | — | — | — | — | — |
| Balance Sheet | |||||||||||||||
| Debt/Equity | 0.04 | 0.04 | 0.06 | 0.12 | 0.15 | — | — | — | — | — | 0.00 | 0.49 | — | — | — |
| Current Ratio | 4.61 | 4.61 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||
| Free Cash Flow | $13.2M | $13.2M | $11.9M | $7.0M | $-15.4M | — | — | $-21.2M | $-22.2M | $-11.0M | $-4.4M | $-2.7M | $-4.0M | $-10.1M | $-4.2M |
| Returns | |||||||||||||||
| ROE | 22.7% | 22.7% | 18.5% | -17.4% | -57.7% | -85.5% | -121.3% | -157.2% | -122.6% | -21.1% | -29.4% | -134.8% | -78.0% | -292.0% | -308.2% |
| Valuation | |||||||||||||||
| P/E | 16.82 | 16.82 | 50.09 | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 15.24 | 15.24 | 42.19 | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 3.94 | 3.94 | 9.34 | 3.85 | 4.67 | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||
| Revenue Growth | 29.9% | 29.9% | 19.2% | 16.0% | — | 13.8% | 28.0% | 46.7% | 48.8% | — | — | — | — | — | — |
| EPS Growth | 81.8% | 81.8% | 257.1% | 70.8% | — | -21.2% | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
16.2%
EPS terminal req.
$0.31
Spread vs growth
65.7%
5Y implied EPS CAGR
13.7%
EPS terminal req.
$0.38
Spread vs growth
68.2%
10Y implied EPS CAGR
11.8%
EPS terminal req.
$0.61
Spread vs growth
70.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-69.9%
Start / end P/E
106.6x → 17.7x
EPS bridge
0.11 → 0.20
Residual
-68.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.